Search results
Supreme Court to take up on July 10 pleas seeking review of its verdict refusing to recognise same...
Tribune India· 3 days agoA five-judge Bench of Chief Justice of India DY Chandrachud, Justice Sanjay Kishan Kaul, Justice S...
BJP replaces state in-charges for HP, Haryana; retains Rupani in Punjab
Tribune India· 2 days agoThe BJP on Friday began its process of organisational overhaul after the 2024 Lok Sabha election...
UP: BJP goes all out for assembly by-elections on 10 seats, ground report being prepared
India TV· 1 day agoAfter a poor performance in the Lok Sabha elections in UP, the BJP has now put all its strength for...
Supreme Court to revisit same-sex marriage ruling on July 10 | India News - Times of India
The Times of India· 2 days agoNEW DELHI: The Supreme Court is set to hear petitions demanding a review of the apex court's...
Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit
CNBC Awaaz· 6 days agoAt the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure...
SC to hear plea seeking review of last year's verdict on same-sex marriage
Firstpost· 2 days agoThe Supreme Court is scheduled to consider on July 10 a batch of pleas seeking a review of its last...
Emcure Pharmaceuticals IPO: Issue booked 4.98 times on the second bidding day. Check latest GMP,...
Livemint· 3 days agoEmcure Pharmaceuticals IPO subscription status: Emcure Pharmaceuticals, backed by Bain Capital,...
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS | Stock...
Livemint· 5 days agoEmcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita...
SC to hear plea challenging its same-sex marriage verdict on July 10
CNBC Awaaz· 2 days agoThe Supreme Court will hear on July 10 a review petition challenging its refusal to grant legal...
Emcure Pharmaceuticals' IPO subscription closes today | India Infoline
India Infoline· 2 days agoOn the third day of bidding, at the time of writing on July 5, 2024 at 12:12 pm, Emcure Pharmaceuticals IPO is witnessing a overall subscription of 8.83 times.